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Summary On 80 occasions 4 iliac biopsy trephines and 4 iliac aspirations were performed in 37 children with
neuroblastoma at various stages of the disease. In 38 of these procedures, tumour cells were detected. In 24%
of cases, both trephines and aspirates were positive, whereas in 63% neuroblastoma cells were detected only
on the trephines and in 13% only on the aspirates. In addition, in 37% of the stagings, only one out of the 8
investigations was abnormal. Only in one of 33 pathological cases, was BM involvement diagnosed on
trephine imprint. No involvement was ever observed on tibial and sternal aspirates without iliac involvement.
Immunological studies with two monoclonal antibodies HSAN 1-2 and UJ13A were performed on 56
occasions. Cytohistological and immunological studies were concordant in 39. In 3 studies, the antigens
recognized by the two monoclonal antibodies were not expressed by the initial tumour and in 3 additional
studies immunological results were falsely negative; but in 11 cases monoclonal antibodies identified residual
malignancy despite normal cytohistology. From this study, biopsies appear more helpful to detect malignant
cells than aspirates. Immunological staining clearly leads to a better definition of tumour cells in aspirates.
The accurate assessment of tumour infiltration in
the bone marrow (BM) of patients with neuro-
blastoma yields important clues for their optimal
management. For children over one year of age,
BM involvement at diagnosis (stage IV) is a clear
indication of poor prognosis. In such cases high
dose chemo-radiotherapy is one of the best avail-
able therapy and autologous BM transplantation
used as a rescue protocol (Shafford et al., 1984;
D'Angio et al., 1985; Philip et al., 1985a). These
transplants can be freed of malignant cells
(purging) when required by detection of minimal
residual disease. Neuroblastoma is a disease with
focal BM involvement and multiple biopsies would
be more appropriate than aspirates for detecting
low levels of tumour cells (Franklin & Pritchard,
1983; Bostrom et al., 1985). However, the relative
values and utility of histological, cytological and
immunological investigations of the bone marrow
are still not fully established. Since 1983, we have
performed extensive investigations (superstaging)
including 4 biopsies and 4 aspirates taken anteriorly
and posteriorly from both iliac crests in all patients.
In addition, 4 BM imprints, 2 tibial aspirates and
one sternal aspirate were also performed on most
of these patients. Recently, monoclonal antibodies
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which selectively bind to cells of neuroectodermal
origin have also been developed (Reynolds et al.,
1982; Kemshead et al., 1983; Allan et al., 1983;
Donner et al., 1985). Two of these antibodies were
used in an indirect immunofluorescence assay to
confirm and extend the detection of neuroblastoma
cells in suspensions of BM cells. In this paper we
assess the relative value of cytological and histo-
logical investigations and the contribution of
immunological analysis to neuroblastoma cell
detection in the BM.
Patients and methods
Only stage IV neuroblastoma (diagnosed on
classical criteria previously reported by Philip et al.,
1985a,b) have been included in this study. Investi-
gations were performed at various stages of the
disease.
Cytological and histological analyses
Trephine biopsies obtained with a Jamshidi needle,
were fixed on formalin, decalcified in Zenkey's
medium and stained with hematein phloxin safran.
Spread films (2 spread films per site) and imprint
preparations of BM trephines were stained by May
Grunwald Giemsa. In 28 of the 80 stagings, BM
aspirated from each site was pooled into
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heparinized bottles (heparine seche, Choay), a
mononuclear cell fraction prepared by centrifuga-
tion on ficoll and cells adjusted to 3 x I05 ml-1 in
PBS. Smears from these preparations were made by
cytocentrifugation of cells onto glass slides (at 70g
for 5min in a Shandon cytospin); these were air
dried and stained with MGG, as described by Bayle
et al. (1985).
Immunological analysis
Immunological analysis was performed on mono-
nuclear cells (BM aspirations on heparin and ficoll
separation as above), resuspended in PBS and
stained by indirect immunofluorescence, as
previously described (Favrot et al., 1984). The 2
monoclonal antibodies UJ13A and HSAN 1-2 bind
to neuroblastoma; they were kindly provided by
J.T. Kemshead (Allan et al., 1983; Kenshead et al.,
1983) and L.P. Reynolds (Reynolds et al., 1982)
respectively. In BM taken from healthy donors,
Table I Histological and cytological analy
investiga
UJ13A stains up to 1% cells and HSAN 1-2 up to
1/1000. In such cases, cells appear single and
lymphoid like whereas neuroblastoma cells are
usually gathered in clumps. Samples were then
classified as normal when fully negative, patho-
logical when more than 3% of isolated cells or any
clumps of cells were stained. When less than 3% of
isolated cells were positive for antibody binding,
results were recorded without interpretation.
Results
Comparison of4 biopsies and 4 aspirates in 80 cases
(see Table I)
In 42 of 80 investigations, the examination of both
trephines and aspirates was normal, whereas BM
involvement was detected in 38. In 24 of these
(63.2% of the pathological cases), neuroblastoma
cells were detected only by biopsy as all 4 aspirates
sis of iliac sites in 20 typical abnormal
Aspirates Biopsies
anterior posterior anterior posterior
right left right left right left right left
E.H. - - - + + - +
_- + + - +
_ _ _ _ ~~~+ + + +
~- + +
C.L. - + _ _
_- - + +
_- + - + +
J.P.N. - - - - - +
~ ~ +
A.P.B. - - - + + + -
~ ~
S.D. - + -
_- + +
S.L. _ _ _ - + - +
S.S. - _ + _ _ _
A.S. - + + - - - -
C.P. + + + - + ± ± +
+ + +
+ + - + - +_ _
D.A. + - - - - + +
(-) normal; (+) pathological.
Thirty-four of the 80 investigations, including biopsies and aspirates in each of the
4 iliac sites, were pathological. Twenty of these investigations (in 10 patients at
various stages of the disease) have been taken as typical examples (see comments in
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were normal. In this group, diagnosis was made by
identifying 1/4 positive biopsy in 11 cases, 2/4 in 8
cases, 3/4 in 4 cases and 4/4 in 1 case. Five patients
of this group given as examples in the Table (E.H.,
C.L., J.P.N., A.P.B., S.D.) had repeated stagings;
BM trephine has been the only way to detect the
presence of neuroblastoma cells in the marrow for
all repeated investigations.
In 5 of the 38 abnormal cases (13.2%) diagnosis
was made only by analysing aspirates as biopsies
were negative. In this group, 1/4 aspirate was
positive in 3 cases and 2/4 in 2 cases (patients S.S.
and A.S. are given as examples in Table I). In the
remaining 9 abnormal cases (patients C.P. and
D.A. in Table I), both cytological and histological
examinations were pathological (at least 1/4 biopsy
and 1/4 aspirate positive). However, analysis of
biopsies and aspirates in these 9 cases were not
fully concordant. Patient D.A. (illustrated in
Table I) had tumour cells in her iliac crest whilst
the aspirates from the same site were negative.
These results, taken together, show that in 36%
cases only 1/8 investigation (4 biopsies+4 aspirates)
showed abnormalities. This variability was already
seen at diagnosis (examples given in Table I): in
patient S.S., 1/4 aspiration was positive with
negative biopsies, patient S.L. had 2/4 positive
biopsies and negative aspirations and patient A.P.B.
(first investigation) had only 3 positive biopsies.
The value ofanalyzing trephine imprints and
additional aspirates
Tumour involvement was detected in the trephines
in 30 cases but only 9 of the same trephines yielded
detectable tumour cells in the imprints. However in
one case the trephines appeared normal and the
analysis of the imprint showed the presence of
tumour cells. Increasing the number of aspirates
was of minimal benefit. Investigation of 65
additional sternal aspirates did not add further
information to that obtained from the iliac crest,
and only in 1/53 cases was a tibial aspirate
abnormal when an iliac crest aspirate appeared to
be tumour free. Even in this case, the trephine
biopsy from iliac crest was positive. Therefore,
when both aspirates and trephine biopsies are
analyzed from the iliac sites, no benefit could be
shown by investigating further aspirates.
The value ofa cytological analysis ofBM
mononuclear cells on smears
In 28 cases, mononuclear cells from pooled
aspirations were separated on a ficoll gradient and
analyzed on smears. Such techniques might be
expected to increase the detection of enriched
neuroblastoma cells by eliminating unwanted cells
such as red cells and mature leucocytes, but the
examination of cytospins has not improved tumour
cell detection. Only 3 of 28 cytospins were positive.
All 3 and another 2 samples contained tumour cells
when studied in aspirates, suggesting the loss of
some malignant clumps on ficoll. In 8 of 28 cases,
both the cytospins and aspirates were negative
while the biopsies were positive.
The relationship between cytological or histological
investigations and immunohistological studies
On 56 occasions histological, cytological and
immunological procedures were compared for their
ability to detect tumour cells in bone marrow.
Twenty-five cases showed normal trephines and
aspirates by conventional histology/cytology. Of
these, 14 were normal by immunohistological
studies. Nevertheless, in 11 investigations performed
on 10 patients, more than 3% of single cells or
clumps were positive for antibody binding. Two of
these patients, with 5% and 13% positive BM cells
(some in clumps), relapsed within 3 weeks of the
study whilst on therapy and both the aspirates and
trephines have become positive. In 4 patients, BM
was harvested for autografting and 5 to 10%
UJ13A positive cells were found before the purging
procedure. These were isolated cells in 3 cases,
clumps in one case. These cells were clearly
eliminated by the immunomagnetic purging process
which was subsequently used to cleanse the BM.
These patients relapsed 5, 5, 4 and 1 months
respectively postgrafting. In one patient, neuro-
blastoma cells in the initial tumour were described
as 'pseudo-lymphomatous', and were therefore
difficult to identify among the normal BM
population. In two successive stagings, more than
10% of UJ13A positive isolated mononuclear cells
were detected. Some of these cells (1-2%) were
HSAN 1-2 positive on one occasion; this patient is
clinically stable 3 months after the last staging
procedure. The other 3 cases with clearly identified
UJ13A positive cells are not clinically evaluable at
this time.
A further 9 cases with UJ13A positivity also
showed abnormality on both trephines and
aspirates. In 8 patients, the immunological studies
were in concordance with cyto-histology. For the
ninth and as mentioned above, malignant cells
clearly observed on aspirates were not identified
either on cytological smears or immunological
samples, suggesting the loss of malignant clumps on
ficoll. Finally, the immunological results were also
helpful in patients where the results of trephine
biopsies and aspirates differed (11 cases). In 9 cases
of this group trephines were classified as abnormal
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and aspirates normal. Immunological studies con-
firmed the presence of isolated tumour cells in 5/9
of these cases with further suggestive, but not
conclusive, findings in favour of tumour cell
involvement (i.e. - 1% cells positive). In 2 cases
where aspirates were found abnormal and trephines
normal, immunological studies identified the
malignant cells only in one case. Finally, in 3/56
cases, the immunological analysis of bone marrow
was not possible with UJ13A and HSAN 1-2
antibodies since the initial tumour did not express
the corresponding antigens.
Discussion
The accurate assessment of BM status is one of the
important steps in the management of children with
neuroblastoma. The metastatic spread may be
focal. As a consequence the analysis of trephines
and samples taken from several sites may improve
diagnosis (Franklin et al., 1983; Bostrom et al.,
1985; Bayle et al., 1985). However, no study has
attempted to define the number of sites and type of
investigation that will maximize tumour cell
detection without overloading the laboratory. From
our study it appears that biopsies are more helpful
at detecting malignant cells than aspirates. In
63.2% of pathological cases, biopsy was the only
technique capable of demonstrating tumour,
probably because neuroblastoma cells are less easily
recognized when the clumps are dissociated.
However, both techniques are necessary as in 13%
of cases only aspirates were positive. The focal
nature of the disorder was demonstrated by the fact
that in 36.7% of cases only 1/8 assays (4
biopsies+4 trephines) were positive, indicating the
need to analyse at least 4 sites by both methods.
Nevertheless, the analysis of aspirates from
additional sites such as sternum and tibia did not
yield better detection. Analysis of trephine imprints
was also unproductive. Furthermore, Bayle et al.
(1985) suggested that cytocentrifuged smears of BM
mononuclear cells should improve the detection of
small aggregates of neuroblastoma cells, mainly by
eliminating contaminating red cells. In our limited
experience, analysis of these smears did not add
useful observation to the diagnosis made on
trephines and/or aspirates. Several authors have
attempted to improve the detection rate of BM
invasion by immunological methods (Reynolds et
al., 1982; Kemshead et al., 1983), and our study
also demonstrates that immunological analysis
improves cytological diagnosis since the immuno-
logical findings were pathological in 9 cases of
positive biopsies with negative aspirates. In
addition, as described for 11 cases in this study,
immunological staining may detect neuroblastoma
cells which are not yet recognizable by traditional
cytological or histological criteria. Such cells need
now to be fully characterized in their cytological
aspect and membrane marker expression in order to
investigate whether the presence of such cells
precedes clinical relapse. The value of immuno-
logical analysis for the detection of minimal
residual BM involvement should then lead to the
further development of the procedure. Indeed, the
MoAb panel used in this study was too restricted
since it did not recognize malignant cells in 5% of
cases; the MoAbs were not fully specific for neuro-
blastoma and for this reason it was difficult to
ascertain whether <I% isolated positive cells were
normal haematopoietic progenitors or neuro-
blastoma cells. Limitations of the method described
here will be solved by using a larger panel of
MoAbs, including some which recognize
cytoplasmic antigens (Gross et al., 1986) and by
characterizing their reactivity on neuroblastoma
cells in trephine biopsies, as described by Chilosi et
al. (1983).
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